ID   M3K3_HUMAN              Reviewed;         626 AA.
AC   Q99759; B2RCW2; D3DU15; Q5BKZ6; Q8N3I9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   15-MAR-2017, entry version 181.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 3;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 3;
DE            Short=MEK kinase 3;
DE            Short=MEKK 3;
GN   Name=MAP3K3; Synonyms=MAPKKK3, MEKK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9006902; DOI=10.1074/jbc.272.5.2668;
RA   Ellinger-Ziegelbauer H.C., Brown K., Kelly K., Siebenlist U.;
RT   "Direct activation of the stress-activated protein kinase (SAPK) and
RT   extracellular signal-regulated protein kinase (ERK) pathways by an
RT   inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK)
RT   derivative.";
RL   J. Biol. Chem. 272:2668-2674(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION AT SER-166 AND SER-337 BY SGK1.
RX   PubMed=12761204; DOI=10.1093/jb/mvg010;
RA   Chun J., Kwon T., Kim D.J., Park I., Chung G., Lee E.J., Hong S.K.,
RA   Chang S.I., Kim H.Y., Kang S.S.;
RT   "Inhibition of mitogen-activated kinase kinase kinase 3 activity
RT   through phosphorylation by the serum- and glucocorticoid-induced
RT   kinase 1.";
RL   J. Biochem. 133:103-108(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MAP2K5.
RX   PubMed=12912994; DOI=10.1074/jbc.C300313200;
RA   Nakamura K., Johnson G.L.;
RT   "PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for
RT   activation of the ERK5 pathway.";
RL   J. Biol. Chem. 278:36989-36992(2003).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH TRAF6.
RX   PubMed=14661019; DOI=10.1038/ni1014;
RA   Huang Q., Yang J., Lin Y., Walker C., Cheng J., Liu Z.G., Su B.;
RT   "Differential regulation of interleukin 1 receptor and Toll-like
RT   receptor signaling by MEKK3.";
RL   Nat. Immunol. 5:98-103(2004).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH TRAF7.
RX   PubMed=14743216; DOI=10.1038/ncb1086;
RA   Bouwmeester T., Bauch A., Ruffner H., Angrand P.-O., Bergamini G.,
RA   Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli S.,
RA   Hopf C., Huhse B., Mangano R., Michon A.-M., Schirle M., Schlegl J.,
RA   Schwab M., Stein M.A., Bauer A., Casari G., Drewes G., Gavin A.-C.,
RA   Jackson D.B., Joberty G., Neubauer G., Rick J., Kuster B.,
RA   Superti-Furga G.;
RT   "A physical and functional map of the human TNF-alpha/NF-kappa B
RT   signal transduction pathway.";
RL   Nat. Cell Biol. 6:97-105(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250; SER-337 AND
RP   SER-340, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250; SER-337 AND
RP   SER-340, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166; SER-250; SER-312;
RP   SER-337 AND SER-340, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-281.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3
CC       transcriptional regulators. {ECO:0000269|PubMed:12912994,
CC       ECO:0000269|PubMed:14661019, ECO:0000269|PubMed:14743216,
CC       ECO:0000269|PubMed:9006902}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-530.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates
CC       in multimolecular complexes. Part of a complex with MAP2K3, RAC1
CC       and CCM2. Interacts with MAP2K5 and SPAG9.
CC       {ECO:0000269|PubMed:12912994, ECO:0000269|PubMed:14661019,
CC       ECO:0000269|PubMed:14743216}.
CC   -!- INTERACTION:
CC       Q13163:MAP2K5; NbExp=2; IntAct=EBI-307281, EBI-307294;
CC       Q6Q0C0:TRAF7; NbExp=2; IntAct=EBI-307281, EBI-307556;
CC       P31946:YWHAB; NbExp=2; IntAct=EBI-307281, EBI-359815;
CC       P62258:YWHAE; NbExp=3; IntAct=EBI-307281, EBI-356498;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99759-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99759-2; Sequence=VSP_035967;
CC   -!- PTM: Phosphorylation at Ser-166 and Ser-337 by SGK1 inhibits its
CC       activity. {ECO:0000269|PubMed:12761204}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U78876; AAB41729.1; -; mRNA.
DR   EMBL; AK315305; BAG37709.1; -; mRNA.
DR   EMBL; AL834303; CAD38973.1; -; mRNA.
DR   EMBL; AC046185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94297.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94298.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94299.1; -; Genomic_DNA.
DR   EMBL; BC090859; AAH90859.1; -; mRNA.
DR   EMBL; BC093672; AAH93672.1; -; mRNA.
DR   EMBL; BC093674; AAH93674.1; -; mRNA.
DR   CCDS; CCDS32701.1; -. [Q99759-2]
DR   CCDS; CCDS32702.1; -. [Q99759-1]
DR   RefSeq; NP_002392.2; NM_002401.3. [Q99759-1]
DR   RefSeq; NP_976226.1; NM_203351.1. [Q99759-2]
DR   UniGene; Hs.29282; -.
DR   PDB; 2C60; X-ray; 1.25 A; A=37-124.
DR   PDB; 2JRH; NMR; -; A=42-126.
DR   PDB; 2O2V; X-ray; 1.83 A; B=37-124.
DR   PDB; 2PPH; NMR; -; A=42-126.
DR   PDB; 4Y5O; X-ray; 2.35 A; B=1-124.
DR   PDB; 4YL6; X-ray; 2.10 A; B=1-22.
DR   PDBsum; 2C60; -.
DR   PDBsum; 2JRH; -.
DR   PDBsum; 2O2V; -.
DR   PDBsum; 2PPH; -.
DR   PDBsum; 4Y5O; -.
DR   PDBsum; 4YL6; -.
DR   ProteinModelPortal; Q99759; -.
DR   SMR; Q99759; -.
DR   BioGrid; 110379; 50.
DR   DIP; DIP-27521N; -.
DR   IntAct; Q99759; 33.
DR   MINT; MINT-272157; -.
DR   STRING; 9606.ENSP00000354927; -.
DR   BindingDB; Q99759; -.
DR   ChEMBL; CHEMBL5970; -.
DR   GuidetoPHARMACOLOGY; 2078; -.
DR   iPTMnet; Q99759; -.
DR   PhosphoSitePlus; Q99759; -.
DR   BioMuta; MAP3K3; -.
DR   DMDM; 160332306; -.
DR   EPD; Q99759; -.
DR   MaxQB; Q99759; -.
DR   PaxDb; Q99759; -.
DR   PeptideAtlas; Q99759; -.
DR   PRIDE; Q99759; -.
DR   DNASU; 4215; -.
DR   Ensembl; ENST00000361357; ENSP00000354927; ENSG00000198909. [Q99759-2]
DR   Ensembl; ENST00000361733; ENSP00000354485; ENSG00000198909. [Q99759-1]
DR   Ensembl; ENST00000579585; ENSP00000461988; ENSG00000198909. [Q99759-2]
DR   GeneID; 4215; -.
DR   KEGG; hsa:4215; -.
DR   UCSC; uc002jbe.4; human. [Q99759-1]
DR   CTD; 4215; -.
DR   DisGeNET; 4215; -.
DR   GeneCards; MAP3K3; -.
DR   HGNC; HGNC:6855; MAP3K3.
DR   HPA; CAB007764; -.
DR   HPA; HPA035410; -.
DR   HPA; HPA035411; -.
DR   MIM; 602539; gene.
DR   neXtProt; NX_Q99759; -.
DR   OpenTargets; ENSG00000198909; -.
DR   PharmGKB; PA30599; -.
DR   eggNOG; KOG0198; Eukaryota.
DR   eggNOG; ENOG410XQGS; LUCA.
DR   GeneTree; ENSGT00800000124036; -.
DR   HOGENOM; HOG000049130; -.
DR   HOVERGEN; HBG006303; -.
DR   InParanoid; Q99759; -.
DR   KO; K04421; -.
DR   OMA; HPNRQSD; -.
DR   OrthoDB; EOG091G038L; -.
DR   PhylomeDB; Q99759; -.
DR   TreeFam; TF105113; -.
DR   BRENDA; 2.7.11.25; 2681.
DR   BRENDA; 2.7.12.2; 2681.
DR   Reactome; R-HSA-446652; Interleukin-1 signaling.
DR   SignaLink; Q99759; -.
DR   SIGNOR; Q99759; -.
DR   ChiTaRS; MAP3K3; human.
DR   EvolutionaryTrace; Q99759; -.
DR   GeneWiki; MAP3K3; -.
DR   GenomeRNAi; 4215; -.
DR   PRO; PR:Q99759; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000198909; -.
DR   CleanEx; HS_MAP3K3; -.
DR   ExpressionAtlas; Q99759; baseline and differential.
DR   Genevisible; Q99759; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:MGI.
DR   GO; GO:0000165; P:MAPK cascade; TAS:ProtInc.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    626       Mitogen-activated protein kinase kinase
FT                                kinase 3.
FT                                /FTId=PRO_0000086245.
FT   DOMAIN       44    123       PB1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01081}.
FT   DOMAIN      362    622       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     368    376       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    489    489       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     391    391       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     147    147       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61084}.
FT   MOD_RES     166    166       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12761204}.
FT   MOD_RES     250    250       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     312    312       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     337    337       Phosphoserine; by SGK1.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12761204}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      42     42       Q -> QKKHNSSSSALLNSPTVTTSSCAGASEKKKFL (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_035967.
FT   VARIANT     281    281       V -> M (in dbSNP:rs36109904).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040685.
FT   VARIANT     325    325       A -> G (in dbSNP:rs34042309).
FT                                /FTId=VAR_037275.
FT   VARIANT     435    435       A -> G (in dbSNP:rs9910858).
FT                                /FTId=VAR_037276.
FT   CONFLICT    135    135       G -> E (in Ref. 1; AAB41729).
FT                                {ECO:0000305}.
FT   HELIX         3     18       {ECO:0000244|PDB:4YL6}.
FT   STRAND       45     51       {ECO:0000244|PDB:2C60}.
FT   STRAND       54     60       {ECO:0000244|PDB:2C60}.
FT   HELIX        66     77       {ECO:0000244|PDB:2C60}.
FT   STRAND       82     86       {ECO:0000244|PDB:2C60}.
FT   HELIX        88     90       {ECO:0000244|PDB:4Y5O}.
FT   STRAND       91     93       {ECO:0000244|PDB:2C60}.
FT   HELIX        97    109       {ECO:0000244|PDB:2C60}.
FT   TURN        111    114       {ECO:0000244|PDB:2JRH}.
FT   STRAND      115    121       {ECO:0000244|PDB:2C60}.
SQ   SEQUENCE   626 AA;  70898 MW;  28129168A57571DD CRC64;
     MDEQEALNSI MNDLVALQMN RRHRMPGYET MKNKDTGHSN RQSDVRIKFE HNGERRIIAF
     SRPVKYEDVE HKVTTVFGQP LDLHYMNNEL SILLKNQDDL DKAIDILDRS SSMKSLRILL
     LSQDRNHNSS SPHSGVSRQV RIKASQSAGD INTIYQPPEP RSRHLSVSSQ NPGRSSPPPG
     YVPERQQHIA RQGSYTSINS EGEFIPETSE QCMLDPLSSA ENSLSGSCQS LDRSADSPSF
     RKSRMSRAQS FPDNRQEYSD RETQLYDKGV KGGTYPRRYH VSVHHKDYSD GRRTFPRIRR
     HQGNLFTLVP SSRSLSTNGE NMGLAVQYLD PRGRLRSADS ENALSVQERN VPTKSPSAPI
     NWRRGKLLGQ GAFGRVYLCY DVDTGRELAS KQVQFDPDSP ETSKEVSALE CEIQLLKNLQ
     HERIVQYYGC LRDRAEKTLT IFMEYMPGGS VKDQLKAYGA LTESVTRKYT RQILEGMSYL
     HSNMIVHRDI KGANILRDSA GNVKLGDFGA SKRLQTICMS GTGMRSVTGT PYWMSPEVIS
     GEGYGRKADV WSLGCTVVEM LTEKPPWAEY EAMAAIFKIA TQPTNPQLPS HISEHGRDFL
     RRIFVEARQR PSAEELLTHH FAQLMY
//
